158
Participants
Start Date
April 29, 2022
Primary Completion Date
April 22, 2025
Study Completion Date
May 12, 2025
Itolizumab
Itolizumab \[Bmab600\]
EQ001 Placebo
EQ001 Placebo
Starship Children's Hospital, Auckland
ULB - Institut Jules Bordet; department of Hematology, Anderlecht
Cliniques Universitaires Saint-Luc; Hematology Department, Brussels
ZNA Stuivenberg, Antwerp
Westmead Hospital, Westmead
UZ Leuven - Campus Gasthuisberg - Department of Hematology, Leuven
Royal Melbourne Hospital, East Melbourne
Austin Health, Heidelberg
CHU de Liege - Hematology Department, Liège
Royal Adelaide Hospital, Adelaide
AZ Sint-Jan Brugge-Oostende AV, Bruges
Hospital de la Santa Creu i Sant Pau, Barcelona
AZ Delta, Roeselare
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
AOU Citta della Salute e della Scienza di Torino - Ospedale Regina Margherita, Torino
Northwell Health, Lake Success
Stony Brook University Medical Center, Stony Brook
Institut Paoli Calmettes - Hematology, Marseille
Charité Universitätsmedizin Berlin, Tumorimmunologie Campus Virchow-Klinikum, Berlin
CHU de Caen - Hopital Femme-Enfant-Hematologie (FEH), Caen
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh
Hospital Universitario Virgen de las Nieves, Granada
University of Pennsylvania Abramson Cancer Center, Philadelphia
Hospital Universitario Donostia, Donostia / San Sebastian
Istituto Clinico Humanitas, Rozzano
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Milan
IRCCS Ospedale San Raffaele, Milan
Fondazione IRCCS San Gerardo dei Tintori, Monza
University of Maryland Medical Center, Baltimore
Wake Forest, Winston-Salem
University of North Carolina (UNC), Chapel Hill
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Clinica Universidad de Navarra - Pamplona, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Marques de Valdecilla, Madrid
Hospital Universitario Regional de Málaga, Málaga
Emory University, Atlanta
CHU Toulouse, Hematology, Toulouse
AdventHealth Orlando, Orlando
CHU Bordeaux - Hopital Haut-Leveque - Centre François Magendie, Pessac
Moffitt Cancer Center, Tampa
CHU de Rennes Hôpital Pontchaillou, Rennes
University of Alabama at Birmingham, Birmingham
Hospital Clinico Universitario de Salamanca, Salamanca
Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona
Sarah Cannon Research Institute, LLC (SCRI), Nashville
CHU de Grenoble Hôpital Michallon, Grenoble
Dipartimento Malattie oncologiche ed ematologiche - U.O. Ematologia - Programma dipartimentale Terapie cellulari avanzate, Bologna
Universitaetsklinikum Duesseldorf, Düsseldorf
Hospital Universitario Virgen del Rocio, Seville
Kyungpook National University Hospital, Daegu
The Ohio State University (OSU), Columbus
University Hospitals Cleveland Medical Center, Cleveland
Oncology Hematology in Cincinnati, Cincinnati
Hospital Clínico Universitario de Valencia, Valencia
Hospital Universitari i Politecnic La Fe, Valencia
University of Michigan, Ann Arbor
Universitätsklinikum Münster, Münster
Henry Ford Hospital, Detroit
Pusan National University Hospital, Busan
Spectrum Health, Grand Rapids
Azienda Ospedaliero-Universitaria Careggi, Florence
Universitaetsklinikum Koeln (AoeR), Cologne
University of Iowa, Iowa City
Mayo Clinic - Rochester, Rochester
Chonnam National University Hwasun Hospital, Hwasun
CHU de Lille - Hopital Claude Huriez, Lille
Loyola University Chicago, performing research at Loyola University Medical Center, Maywood
Northwestern Memorial Hospital, Chicago
The University of Chicago Medical Center (UCMC), Chicago
CHU de Nantes - Hôtel-Dieu, Lyon
HCL Centre Hospitalier Lyon Sud, Pierre-Bénite
Tulane University Medical Center, New Orleans
AP-HP Hopital Saint-Louis, Paris
Baylor Scott & White Research Institute, Dallas
UT Southwestern Medical Center, Dallas
CHU Amiens Picardie - Hopital Sud, Amiens
Universitaetsklinikum Ulm, Ulm
"Grande Ospedale Metropolitano Bianchi Melacrino Morelli", Reggio Calabria
University of Southern California, Los Angeles
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
City of Hope, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Stanford Cancer Center, Stanford
Institut Gustave Roussy - Hematology, Villejuif
Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco- Presidio Ospedaliero Ferrarotto Alessi, Catania
Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg
Oregon Health & Science University (OHSU), Portland
Fred Hutchinson Cancer Research Center, Seattle
Rambam Health Care Campus, Haifa
Bone Marrow Transplantation Unit Rabin MC, Petah Tikva
Chaim Sheba Medical Center, Tel Litwinsky
Tel Aviv Sourasky Medical Center, Tel Aviv
Hadassah Medical Center Ein Karem, Jerusalem
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
John Theurer Cancer Center At Hackensack UMC, Hackensack
Rutgers Cancer Institute of NJ, New Brunswick
Vancouver Coastal Health Authority, Vancouver
Princess Margaret Hospital, Toronto
McGill University Health Center - Research Institute, Montreal
CHU de Québec - Université Laval, Québec
University of Saskatchewan, Saskatoon
CHU Nice, Hospital l'Archet, Nice
Martin Luther Universitat Halle-Wittenberg, Halle
Universitätsklinikum Jena, Jena
Universitaetsklinikum Leipzig, Leipzig
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome
Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Clinic Barcelona, Barcelona
Institut Catala d'Oncologia - L'Hospitalet, Barcelona
Lead Sponsor
Biocon Limited
INDUSTRY
Equillium
INDUSTRY